Back to search

Chronos Therapeutics Limited

06838479

active
Private Limited Company
Companies House
Health Score
90 / 100

Healthy

30/30
Filing
20/30
Financial
40/40
Risk

No risk factors detected.

Details

THERACRYF PLC ALDERLEY PARK, NETHER ALDERLEY, SK10 4TG
Incorporated 05/03/2009

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72190
Other research and experimental development on natural sciences and engineering

Officers

Toni Markus Antero Haenninen

director · Since 05/04/2024

CHIEF FINANCIAL OFFICER

FINNISH · SWITZERLAND · Age 48

Dr Huw Jones

director · Since 05/04/2024

CHIEF EXECUTIVE

BRITISH · UNITED KINGDOM · Age 66

Persons with Significant Control

Theracryf Plc

75–100% shares
75–100% votes
Appoint directors

Alderley Park, Congleton Road, Nether Alderley, SK10 4TG

Reg: 09246681 · Companies House · Public Limited Company

Notified 05/04/2024

CompanyRankvs 3438+ SIC 72190 peers
50

Financial strength61th percentile among SIC peers · 15/25
Employees20th percentile among SIC peers · 3/15
LiquidityCurrent ratio 0.17× · 2/20
Longevity15 years trading (max 15) · 15/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength15/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees3/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity2/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity15/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/03/2025

Net Worth

£5k

Balance sheet strength

Cash

£38k

Cash in the bank

Net Current Assets

-£284k

Working capital

Current Assets

£58k

Current Liabilities

£342k

Debtors

£20k

0avg. employees-1

Balance Sheet

Intangible assets£443k
Assets less current liabilities£159k
Prepared with IRIS Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
20250.17+£0
20240.13

Derived from filed accounts. Not audited figures.